Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine.
about
Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Inhibition of CHK1 sensitizes ...... ductase inhibitor gemcitabine.
@en
Inhibition of CHK1 sensitizes ...... ductase inhibitor gemcitabine.
@nl
type
label
Inhibition of CHK1 sensitizes ...... ductase inhibitor gemcitabine.
@en
Inhibition of CHK1 sensitizes ...... ductase inhibitor gemcitabine.
@nl
prefLabel
Inhibition of CHK1 sensitizes ...... ductase inhibitor gemcitabine.
@en
Inhibition of CHK1 sensitizes ...... ductase inhibitor gemcitabine.
@nl
P2093
P2860
P356
P1433
P1476
Inhibition of CHK1 sensitizes ...... eductase inhibitor gemcitabine
@en
P2093
Kathryn M Harmoney
Kelli L Goss
Stacia L Koppenhafer
P2860
P304
87016-87032
P356
10.18632/ONCOTARGET.18776
P407
P577
2017-06-28T00:00:00Z